| Literature DB >> 28420824 |
Tsuyoshi Hatakeyama1, Yasuto Kunii1,2, Itaru Miura1, Shuntaro Itagaki1, Soichi Kono1, Tetsuya Shiga1, Sachie Oshima1, Keiko Nozaki1, Rieko Suzuki1, Hirooki Yabe1.
Abstract
The clinical course of schizophrenia is characterized by recurrence and chronicity and has a large burden on society. Nevertheless, diagnosis of schizophrenia is based only on distinctive symptoms and the disease course. Near-infrared spectroscopy (NIRS) is a useful method for measuring changes in the hemoglobin concentration in the cortical surface area and reflects brain function. We measured NIRS four times during the clinical course in a patient with first-episode schizophrenia.A 17-year-old woman admitted to our hospital because of hallucinations, delusions and appetite loss. After treatment with low-dose antipsychotics, NIRS findings showed a prompt increase in the cerebral blood volume in the frontal region. On the basis of the clinical course of this patient, we introduce a new point of view, namely, that NIRS findings may be useful as a state marker that indicates the severity of schizophrenia in some cases.Entities:
Keywords: biomarker; homovanillic acid; near-infrared spectroscopy; schizophrenia; state marker
Mesh:
Substances:
Year: 2017 PMID: 28420824 PMCID: PMC5476820 DOI: 10.5387/fms.2016-22
Source DB: PubMed Journal: Fukushima J Med Sci ISSN: 0016-2590